Deleault KM, Skinner SJ, Brooks SA Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways. Mol Immunol 2008 Jan; 45(1):13-24 PMID: 17606294 [PubMed - indexed for MEDLINE]
Rigby WF, Roy K, Collins J, Rigby S, Connolly JE, Bloch DB, Brooks SA Structure/function analysis of tristetraprolin (TTP): p38 stress-activated protein kinase and lipopolysaccharide stimulation do not alter TTP function. J Immunol 2005 Jun 15; 174(12):7883-93 PMID: 15944294 [PubMed - indexed for MEDLINE]
Brooks SA, Connolly JE, Rigby WF The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway. J Immunol 2004 Jun 15; 172(12):7263-71 PMID: 15187101 [PubMed - indexed for MEDLINE]
Brooks SA, Connolly JE, Diegel RJ, Fava RA, Rigby WF Analysis of the function, expression, and subcellular distribution of human tristetraprolin. Arthritis Rheum 2002 May; 46(5):1362-70 PMID: 12115244 [PubMed - indexed for MEDLINE]
Professional Interests:
Posttranscriptional Regulation of Cytokine Expression
The primary focus of our lab is the study of posttranscriptional regulation of TNF-a. TNF-a is a central mediator of inflammation and is critical to the control of infection and activation of immune response. TNF-a overexpression contributes to a number of disease states, including rheumatoid arthritis, Crohn's Disease, and the cachexia associated with AIDS and malignancy.
At the molecular level, TNF-a biosynthesis is largely regulated at the levels of mRNA stability and translation, each of which is orders of magnitude more important than regulation of gene transcription. The importance of TNF-a post-transcriptional regulation in disease was demonstrated with the generation of mice containing a germ line deletion of the TNF-a 3'UTR ARE. Macrophages and T cells from these mice produced 3 to 10 fold more TNF-a protein than their wild-type counterparts. This effect was mediated solely through increased TNF-a mRNA stability and translation. In addition to insights into the regulation of TNF-a biosynthesis, the relevance of these mice was apparent by the spontaneous development of disease pathology indistinguishable from Rheumatoid Arthritis, Crohn¡¦s Disease and cachexia.
We are currently studying several proteins involved in TNF-a posttranscriptional regulation, including tristetraprolin (TTP), which regulates TNF-a mRNA stability in monocyte/macrophages. Loss of TTP results in increased TNF-a message stability and a consequent increase in TNF-a protein expression, resulting in inflammatory arthritis and cachexia in TTP (-/-) animals. We are also in the process of characterizing the role of several additional proteins we have identified as specifically interacting with the TNF-a 3'UTR In Vivo.
Cancer Immunotherapy
We are also involved in a larger collaborative effort in cancer immunotherapy. These studies focus on the development and optimization dendritic cell based vaccine strategies.
Courses Taught:
Grant Information:
VA Merit Award - 2005-2008. Identification of Proteins Mediating Posttranscriptional TNFa Expression
VA MREP Award - 2002-2005. Characterization of the Mechanism of Action of TTP on mRNA Stability
Hitchcock Foundation - 2003. Identification of the In Vivo mRNA Ligands of Tristetraprolin in Monocytes
Arthrits Foundation Post Doctoral Fellowship - 2000-2002. Identification and Characterization of TTP Interacting Proteins
NRSA Post Doctoral Fellowship -1998-2000. Identification of the mRNA ligands bound by hnRNP A2